デフォルト表紙
市場調査レポート
商品コード
1679591

動物用ファーマコビジランス市場規模、シェア、動向分析レポート:ソリューション別、タイプ別、製品タイプ別、動物タイプ別、地域別、セグメント別予測、2025年~2030年

Veterinary Pharmacovigilance Market Size, Share & Trends Analysis Report By Solution (Software, Services), By Type (In-house), By Product (Anti-Infective) By Animal Type (Dogs, Cats), By Region, And Segment Forecasts, 2025 - 2030


出版日
ページ情報
英文 130 Pages
納期
2~10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
動物用ファーマコビジランス市場規模、シェア、動向分析レポート:ソリューション別、タイプ別、製品タイプ別、動物タイプ別、地域別、セグメント別予測、2025年~2030年
出版日: 2025年02月26日
発行: Grand View Research
ページ情報: 英文 130 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

動物用ファーマコビジランス市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の動物用ファーマコビジランス市場規模は、2025~2030年にかけて13.6%のCAGRを記録し、2030年までに19億1,000万米ドルに達すると予測されています。

この市場は、動物における医薬品副作用の発生率の増加、コンパニオンアニマルの導入の増加、動物由来食品の需要の増加など、いくつかの要因によって牽引されています。さらに、規制当局のモニタリングの強化や厳格な安全基準の必要性から、新たなファーマコビジランス技術やツールの開発も進んでいます。例えばAccentureは、ICSR症例処理、VeDDRAコーディング、シグナル検出、文献管理、EvVetMPDサポート、規制情報を含む、一連の動物用ファーマコビジランスサービスを提供しています。集計報告、迅速な報告、シグナル管理に対する産業の要求の高まりが、今後数年間の市場成長を促進すると予想されます。

COVID-19の大流行は、動物用医薬品市場にネガティブな影響とポジティブな影響の両方をもたらしました。課題を生み出した一方で、企業が適応し革新する機会も生み出し、世界の健康危機の中で動物用医薬品の安全性と有効性をモニタリングすることの重要性を浮き彫りにしました。これは、動物用ファーマコビジランスソリューションに対する認識と採用を後押ししました。このセグメントは、動物医療市場の新興セグメントです。このセグメントでは、動物用医薬品、ワクチン、その他の動物用医薬品の安全性と有効性をモニタリングし、副作用や事故が発生した場合は報告します。動物福祉に対する関心の高まりと、動物由来の食品に対する需要の増加に伴い、この市場は近年大きな注目を集めています。

主要市場参入企業による取り組みも、市場成長を後押しする要因の一つです。2018年6月、Medfilesは日本に新オフィスを開設し、欧州と日本の顧客にさまざまなサービスを提供しています。これにはファーマコビジランス、臨床検査、分析サービスなどが含まれます。2022年2月、市場の主要参入企業であるEnnovは、北米市場での成功的な成長に対応するため、米国に新オフィスを開設しました。これにより、ファーマコビジランス能力の強化に重点を置いた同社の世界の事業展開が拡大しました。Ennovのファーマコビジランスサービスには、ヒトと動物用ライフサイエンス市場の顧客に対する症例の取り込み、トリアージ、シグナル検出と管理が含まれます。

動物用ファーマコビジランス市場レポートのハイライト

  • 動物用ファーマコビジランス市場の主要動向の1つは、電子報告システムやデータ分析ツールなどの新技術の採用です。これらの技術は有害事象のより効率的で正確なモニタリングを可能にし、潜在的な安全性の問題が深刻化する前に特定するのに役立ちます。
  • ソフトウェアセグメントは世界の獣医療用ファーマコビジランス産業を支配し、2024年には51.0%の最大の売上シェアを占めました。
  • 製品別では、抗感染症薬が2024年に45.4%以上の最大シェアを占めました。一方、生物製剤セグメントは、今後数年間で14%を超える高い成長率を示すと推定されます。
  • 自社部門は、2024年に54.4%の最大収益シェアで市場をリードしました。
  • 動物用ファーマコビジランス産業では、犬が2024年に50.0%の最高収益シェアを獲得し、支配的な地位を占めました。
  • 北米は2024年の地域別市場シェアで約40%を占め、市場を独占しています。アジア太平洋は、2025~2030年にかけて15.4%以上の最速成長率で成長すると推定されています。
  • 動物用ファーマコビジランス市場は、イノベーションを起こし、差別化を図り、動物用医薬品産業の進化するニーズに対応できる企業に大きな機会を記載しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 動物用ファーマコビジランス市場の変数、動向、範囲

  • 市場系統の展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • ビジネス環境分析
    • 産業分析-ポーターのファイブフォース分析
    • PESTLE分析

第4章 動物用ファーマコビジランス市場:ソリューション別ビジネス分析

  • ソリューション別市場シェア、2024年と2030年
  • ソリューションセグメントダッシュボード
  • 市場規模と予測と動向分析、ソリューション別、2018~2030年
  • ソフトウェア
  • サービス

第5章 動物用ファーマコビジランス市場:タイプ別ビジネス分析

  • タイプ別市場シェア、2024年と2030年
  • タイプセグメントダッシュボード
  • 市場規模と予測と動向分析、タイプ別、2018~2030年
  • 社内
  • 契約アウトソーシング

第6章 動物用ファーマコビジランス市場:製品別ビジネス分析

  • 製品別市場シェア、2024年と2030年
  • 製品セグメントダッシュボード
  • 市場規模と予測と動向分析、製品別、2018~2030年
  • 生物製剤
  • 抗感染症薬
  • その他

第7章 動物用ファーマコビジランス市場:動物タイプ別ビジネス分析

  • 動物タイプ別市場シェア、2024年と2030年
  • 動物タイプセグメントダッシュボード
  • 市場規模と予測と動向分析、動物タイプ別、2018~2030年
  • その他の動物タイプ

第8章 動物用ファーマコビジランス市場:地域別、推定・動向分析

  • 地域別市場シェア分析、2024年と2030年
  • 地域別市場ダッシュボード
  • 市場規模、予測動向分析、2018~2030年
  • 北米
    • 国別、2018~2030年
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 国別、2018~2030年
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 国別、2018~2030年
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • 国別、2018~2030年
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 国別、2018~2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第9章 競合情勢

  • 参加者概要
  • 企業の市況分析
  • 企業分類
  • 戦略マッピング
  • 企業プロファイル/上場企業
    • ArisGlobal
    • Accenture
    • Ennov
    • Sarjen Systems Pvt. Ltd.
    • Pharsafer Associates Limited
    • Knoell
    • Biologit
    • Indivirtus
    • Azierta Contract Science Support Consulting
    • Oy Medfiles Ltd.
図表

List of Tables

  • Table 1. List Of Secondary Sources
  • Table 2. List Of Abbreviations
  • Table 3. Global Veterinary Pharmacovigilance Market, By Region, 2018 - 2030 (USD Million)
  • Table 4. Global Veterinary Pharmacovigilance Market, By Solution, 2018 - 2030 (USD Million)
  • Table 5. Global Veterinary Pharmacovigilance Market, By Type, 2018 - 2030 (USD Million)
  • Table 6. Global Veterinary Pharmacovigilance Market, By Product, 2018 - 2030 (USD Million)
  • Table 7. Global Veterinary Pharmacovigilance Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 8. North America Veterinary Pharmacovigilance Market, By Country, 2018 - 2030 (USD Million)
  • Table 9. North America Veterinary Pharmacovigilance Market, By Solution, 2018 - 2030 (USD Million)
  • Table 10. North America Veterinary Pharmacovigilance Market, By Type, 2018 - 2030 (USD Million)
  • Table 11. North America Veterinary Pharmacovigilance Market, By Product, 2018 - 2030 (USD Million)
  • Table 12. North America Veterinary Pharmacovigilance Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 13. U.S. Veterinary Pharmacovigilance Market, By Solution, 2018 - 2030 (USD Million)
  • Table 14. U.S. Veterinary Pharmacovigilance Market, By Type, 2018 - 2030 (USD Million)
  • Table 15. U.S. Veterinary Pharmacovigilance Market, By Product, 2018 - 2030 (USD Million)
  • Table 16. U.S. Veterinary Pharmacovigilance Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 17. Canada Veterinary Pharmacovigilance Market, By Solution, 2018 - 2030 (USD Million)
  • Table 18. Canada Veterinary Pharmacovigilance Market, By Type, 2018 - 2030 (USD Million)
  • Table 19. Canada Veterinary Pharmacovigilance Market, By Product, 2018 - 2030 (USD Million)
  • Table 20. Canada Veterinary Pharmacovigilance Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 21. Mexico Veterinary Pharmacovigilance Market, By Solution, 2018 - 2030 (USD Million)
  • Table 22. Mexico Veterinary Pharmacovigilance Market, By Type, 2018 - 2030 (USD Million)
  • Table 23. Mexico Veterinary Pharmacovigilance Market, By Product, 2018 - 2030 (USD Million)
  • Table 24. Mexico Veterinary Pharmacovigilance Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 25. Europe Veterinary Pharmacovigilance Market, By Country, 2018 - 2030 (USD Million)
  • Table 26. Europe Veterinary Pharmacovigilance Market, By Solution, 2018 - 2030 (USD Million)
  • Table 27. Europe Veterinary Pharmacovigilance Market, By Type, 2018 - 2030 (USD Million)
  • Table 28. Europe Veterinary Pharmacovigilance Market, By Product, 2018 - 2030 (USD Million)
  • Table 29. Europe Veterinary Pharmacovigilance Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 30. Germany Veterinary Pharmacovigilance Market, By Solution, 2018 - 2030 (USD Million)
  • Table 31. Germany Veterinary Pharmacovigilance Market, By Type, 2018 - 2030 (USD Million)
  • Table 32. Germany Veterinary Pharmacovigilance Market, By Product, 2018 - 2030 (USD Million)
  • Table 33. Germany Veterinary Pharmacovigilance Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 34. UK Veterinary Pharmacovigilance Market, By Solution, 2018 - 2030 (USD Million)
  • Table 35. UK Veterinary Pharmacovigilance Market, By Type, 2018 - 2030 (USD Million)
  • Table 36. UK Veterinary Pharmacovigilance Market, By Product, 2018 - 2030 (USD Million)
  • Table 37. UK Veterinary Pharmacovigilance Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 38. France Veterinary Pharmacovigilance Market, By Solution, 2018 - 2030 (USD Million)
  • Table 39. France Veterinary Pharmacovigilance Market, By Type, 2018 - 2030 (USD Million)
  • Table 40. France Veterinary Pharmacovigilance Market, By Product, 2018 - 2030 (USD Million)
  • Table 41. France Veterinary Pharmacovigilance Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 42. Italy Veterinary Pharmacovigilance Market, By Solution, 2018 - 2030 (USD Million)
  • Table 43. Italy Veterinary Pharmacovigilance Market, By Type, 2018 - 2030 (USD Million)
  • Table 44. Italy Veterinary Pharmacovigilance Market, By Product, 2018 - 2030 (USD Million)
  • Table 45. Italy Veterinary Pharmacovigilance Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 46. Spain Veterinary Pharmacovigilance Market, By Solution, 2018 - 2030 (USD Million)
  • Table 47. Spain Veterinary Pharmacovigilance Market, By Type, 2018 - 2030 (USD Million)
  • Table 48. Spain Veterinary Pharmacovigilance Market, By Product, 2018 - 2030 (USD Million)
  • Table 49. Spain Veterinary Pharmacovigilance Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 50. Denmark Veterinary Pharmacovigilance Market, By Solution, 2018 - 2030 (USD Million)
  • Table 51. Denmark Veterinary Pharmacovigilance Market, By Type, 2018 - 2030 (USD Million)
  • Table 52. Denmark Veterinary Pharmacovigilance Market, By Product, 2018 - 2030 (USD Million)
  • Table 53. Denmark Veterinary Pharmacovigilance Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 54. Sweden Veterinary Pharmacovigilance Market, By Solution, 2018 - 2030 (USD Million)
  • Table 55. Sweden Veterinary Pharmacovigilance Market, By Type, 2018 - 2030 (USD Million)
  • Table 56. Sweden Veterinary Pharmacovigilance Market, By Product, 2018 - 2030 (USD Million)
  • Table 57. Sweden Veterinary Pharmacovigilance Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 58. Norway Veterinary Pharmacovigilance Market, By Solution, 2018 - 2030 (USD Million)
  • Table 59. Norway Veterinary Pharmacovigilance Market, By Type, 2018 - 2030 (USD Million)
  • Table 60. Norway Veterinary Pharmacovigilance Market, By Product, 2018 - 2030 (USD Million)
  • Table 61. Norway Veterinary Pharmacovigilance Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 62. Asia Pacific Veterinary Pharmacovigilance Market, By Country, 2018 - 2030 (USD Million)
  • Table 63. Asia Pacific Veterinary Pharmacovigilance Market, By Solution, 2018 - 2030 (USD Million)
  • Table 64. Asia Pacific Veterinary Pharmacovigilance Market, By Type, 2018 - 2030 (USD Million)
  • Table 65. Asia Pacific Veterinary Pharmacovigilance Market, By Product, 2018 - 2030 (USD Million)
  • Table 66. Asia Pacific Veterinary Pharmacovigilance Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 67. Japan Veterinary Pharmacovigilance Market, By Solution, 2018 - 2030 (USD Million)
  • Table 68. Japan Veterinary Pharmacovigilance Market, By Type, 2018 - 2030 (USD Million)
  • Table 69. Japan Veterinary Pharmacovigilance Market, By Product, 2018 - 2030 (USD Million)
  • Table 70. Japan Veterinary Pharmacovigilance Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 71. China Veterinary Pharmacovigilance Market, By Solution, 2018 - 2030 (USD Million)
  • Table 72. China Veterinary Pharmacovigilance Market, By Type, 2018 - 2030 (USD Million)
  • Table 73. China Veterinary Pharmacovigilance Market, By Product, 2018 - 2030 (USD Million)
  • Table 74. China Veterinary Pharmacovigilance Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 75. India Veterinary Pharmacovigilance Market, By Solution, 2018 - 2030 (USD Million)
  • Table 76. India Veterinary Pharmacovigilance Market, By Type, 2018 - 2030 (USD Million)
  • Table 77. India Veterinary Pharmacovigilance Market, By Product, 2018 - 2030 (USD Million)
  • Table 78. India Veterinary Pharmacovigilance Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 79. Australia Veterinary Pharmacovigilance Market, By Solution, 2018 - 2030 (USD Million)
  • Table 80. Australia Veterinary Pharmacovigilance Market, By Type, 2018 - 2030 (USD Million)
  • Table 81. Australia Veterinary Pharmacovigilance Market, By Product, 2018 - 2030 (USD Million)
  • Table 82. Australia Veterinary Pharmacovigilance Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 83. South Korea Veterinary Pharmacovigilance Market, By Solution, 2018 - 2030 (USD Million)
  • Table 84. South Korea Veterinary Pharmacovigilance Market, By Type, 2018 - 2030 (USD Million)
  • Table 85. South Korea Veterinary Pharmacovigilance Market, By Product, 2018 - 2030 (USD Million)
  • Table 86. South Korea Veterinary Pharmacovigilance Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 87. Thailand Veterinary Pharmacovigilance Market, By Solution, 2018 - 2030 (USD Million)
  • Table 88. Thailand Veterinary Pharmacovigilance Market, By Type, 2018 - 2030 (USD Million)
  • Table 89. Thailand Veterinary Pharmacovigilance Market, By Product, 2018 - 2030 (USD Million)
  • Table 90. Thailand Veterinary Pharmacovigilance Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 91. Latin America Veterinary Pharmacovigilance Market, By Country, 2018 - 2030 (USD Million)
  • Table 92. Latin America Veterinary Pharmacovigilance Market, By Solution, 2018 - 2030 (USD Million)
  • Table 93. Latin America Veterinary Pharmacovigilance Market, By Type, 2018 - 2030 (USD Million)
  • Table 94. Latin America Veterinary Pharmacovigilance Market, By Product, 2018 - 2030 (USD Million)
  • Table 95. Latin America Veterinary Pharmacovigilance Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 96. Brazil Veterinary Pharmacovigilance Market, By Solution, 2018 - 2030 (USD Million)
  • Table 97. Brazil Veterinary Pharmacovigilance Market, By Type, 2018 - 2030 (USD Million)
  • Table 98. Brazil Veterinary Pharmacovigilance Market, By Product, 2018 - 2030 (USD Million)
  • Table 99. Brazil Veterinary Pharmacovigilance Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 100. Argentina Veterinary Pharmacovigilance Market, By Solution, 2018 - 2030 (USD Million)
  • Table 101. Argentina Veterinary Pharmacovigilance Market, By Type, 2018 - 2030 (USD Million)
  • Table 102. Argentina Veterinary Pharmacovigilance Market, By Product, 2018 - 2030 (USD Million)
  • Table 103. Argentina Veterinary Pharmacovigilance Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 104. Middle East & Africa Veterinary Pharmacovigilance Market, By Country, 2018 - 2030 (USD Million)
  • Table 105. Middle East & Africa Veterinary Pharmacovigilance Market, By Solution, 2018 - 2030 (USD Million)
  • Table 106. Middle East & Africa Veterinary Pharmacovigilance Market, By Type, 2018 - 2030 (USD Million)
  • Table 107. Middle East & Africa Veterinary Pharmacovigilance Market, By Product, 2018 - 2030 (USD Million)
  • Table 108. Middle East & Africa Veterinary Pharmacovigilance Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 109. South Africa Veterinary Pharmacovigilance Market, By Solution, 2018 - 2030 (USD Million)
  • Table 110. South Africa Veterinary Pharmacovigilance Market, By Type, 2018 - 2030 (USD Million)
  • Table 111. South Africa Veterinary Pharmacovigilance Market, By Product, 2018 - 2030 (USD Million)
  • Table 112. South Africa Veterinary Pharmacovigilance Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 113. Saudi Arabia Veterinary Pharmacovigilance Market, By Solution, 2018 - 2030 (USD Million)
  • Table 114. Saudi Arabia Veterinary Pharmacovigilance Market, By Type, 2018 - 2030 (USD Million)
  • Table 115. Saudi Arabia Veterinary Pharmacovigilance Market, By Product, 2018 - 2030 (USD Million)
  • Table 116. Saudi Arabia Veterinary Pharmacovigilance Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 117. UAE Veterinary Pharmacovigilance Market, By Solution, 2018 - 2030 (USD Million)
  • Table 118. UAE Veterinary Pharmacovigilance Market, By Type, 2018 - 2030 (USD Million)
  • Table 119. UAE Veterinary Pharmacovigilance Market, By Product, 2018 - 2030 (USD Million)
  • Table 120. UAE Veterinary Pharmacovigilance Market, By Animal Type, 2018 - 2030 (USD Million)
  • Table 121. Kuwait Veterinary Pharmacovigilance Market, By Solution, 2018 - 2030 (USD Million)
  • Table 122. Kuwait Veterinary Pharmacovigilance Market, By Type, 2018 - 2030 (USD Million)
  • Table 123. Kuwait Veterinary Pharmacovigilance Market, By Product, 2018 - 2030 (USD Million)
  • Table 124. Kuwait Veterinary Pharmacovigilance Market, By Animal Type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Veterinary Pharmacovigilance Market Segmentation
  • Fig. 2 Market Research Process
  • Fig. 3 Data Triangulation Techniques
  • Fig. 4 Primary Research Pattern
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 Market Formulation & Validation
  • Fig. 8 Market Snapshot
  • Fig. 9 Solution and Type Outlook (USD Million)
  • Fig. 10 Product and Animal Type Outlook (USD Million)
  • Fig. 11 Competitive Landscape
  • Fig. 12 Veterinary Pharmacovigilance Market Dynamics
  • Fig. 13 Veterinary Pharmacovigilance Market: Porter's Five Forces Analysis
  • Fig. 14 Veterinary Pharmacovigilance Market: PESTLE Analysis
  • Fig. 15 Veterinary Pharmacovigilance Market: Solution Segment Dashboard
  • Fig. 16 Veterinary Pharmacovigilance Market: Solution Market Share Analysis, 2024 & 2030
  • Fig. 17 Software Market, 2018 - 2030 (USD Million)
  • Fig. 18 Services Market, 2018 - 2030 (USD Million)
  • Fig. 19 Veterinary Pharmacovigilance Market: Type Segment Dashboard
  • Fig. 20 Veterinary Pharmacovigilance Market: Type Market Share Analysis, 2024 & 2030
  • Fig. 21 In-house Market, 2018 - 2030 (USD Million)
  • Fig. 22 Contract Outsourcing Market, 2018 - 2030 (USD Million)
  • Fig. 23 Veterinary Pharmacovigilance Market: Product Segment Dashboard
  • Fig. 24 Veterinary Pharmacovigilance Market: Product Market Share Analysis, 2024 & 2030
  • Fig. 25 Biologics Market, 2018 - 2030 (USD Million)
  • Fig. 26 Anti-Infective Market, 2018 - 2030 (USD Million)
  • Fig. 27 Other Product Market, 2018 - 2030 (USD Million)
  • Fig. 28 Veterinary Pharmacovigilance Market: Animal Type Segment Dashboard
  • Fig. 29 Veterinary Pharmacovigilance Market: Animal Type Market Share Analysis, 2024 & 2030
  • Fig. 30 Dogs Market, 2018 - 2030 (USD Million)
  • Fig. 31 Cats Market, 2018 - 2030 (USD Million)
  • Fig. 32 Other Animal Types Market, 2018 - 2030 (USD Million)
  • Fig. 33 Veterinary Pharmacovigilance Market Revenue, By Region
  • Fig. 34 Regional Marketplace: Key Takeaways
  • Fig. 35 Regional Marketplace: Key Takeaways
  • Fig. 36 North America Veterinary Pharmacovigilance Market, 2018 - 2030 (USD Million)
  • Fig. 37 U.S. Country Dynamics
  • Fig. 38 U.S. Veterinary Pharmacovigilance Market, 2018 - 2030 (USD Million)
  • Fig. 39 Canada Country Dynamics
  • Fig. 40 Canada Veterinary Pharmacovigilance Market, 2018 - 2030 (USD Million)
  • Fig. 41 Mexico Country Dynamics
  • Fig. 42 Mexico Veterinary Pharmacovigilance Market, 2018 - 2030 (USD Million)
  • Fig. 43 Europe Veterinary Pharmacovigilance Market, 2018 - 2030 (USD Million)
  • Fig. 44 Germany Country Dynamics
  • Fig. 45 Germany Veterinary Pharmacovigilance Market, 2018 - 2030 (USD Million)
  • Fig. 46 UK Country Dynamics
  • Fig. 47 UK Veterinary Pharmacovigilance Market, 2018 - 2030 (USD Million)
  • Fig. 48 France Country Dynamics
  • Fig. 49 France Veterinary Pharmacovigilance Market, 2018 - 2030 (USD Million)
  • Fig. 50 Italy Country Dynamics
  • Fig. 51 Italy Veterinary Pharmacovigilance Market, 2018 - 2030 (USD Million)
  • Fig. 52 Spain Country Dynamics
  • Fig. 53 Spain Veterinary Pharmacovigilance Market, 2018 - 2030 (USD Million)
  • Fig. 54 Norway Country Dynamics
  • Fig. 55 Norway Veterinary Pharmacovigilance Market, 2018 - 2030 (USD Million)
  • Fig. 56 Sweden Country Dynamics
  • Fig. 57 Sweden Veterinary Pharmacovigilance Market, 2018 - 2030 (USD Million)
  • Fig. 58 Denmark Country Dynamics
  • Fig. 59 Denmark Veterinary Pharmacovigilance Market, 2018 - 2030 (USD Million)
  • Fig. 60 Asia Pacific Veterinary Pharmacovigilance Market, 2018 - 2030 (USD Million)
  • Fig. 61 Japan Country Dynamics
  • Fig. 62 Japan Veterinary Pharmacovigilance Market, 2018 - 2030 (USD Million)
  • Fig. 63 China Country Dynamics
  • Fig. 64 China Veterinary Pharmacovigilance Market, 2018 - 2030 (USD Million)
  • Fig. 65 India Country Dynamics
  • Fig. 66 India Veterinary Pharmacovigilance Market, 2018 - 2030 (USD Million)
  • Fig. 67 Australia Country Dynamics
  • Fig. 68 Australia Veterinary Pharmacovigilance Market, 2018 - 2030 (USD Million)
  • Fig. 69 South Korea Country Dynamics
  • Fig. 70 South Korea Veterinary Pharmacovigilance Market, 2018 - 2030 (USD Million)
  • Fig. 71 Thailand Country Dynamics
  • Fig. 72 Thailand Veterinary Pharmacovigilance Market, 2018 - 2030 (USD Million)
  • Fig. 73 Latin America Veterinary Pharmacovigilance Market, 2018 - 2030 (USD Million)
  • Fig. 74 Brazil Country Dynamics
  • Fig. 75 Brazil Veterinary Pharmacovigilance Market, 2018 - 2030 (USD Million)
  • Fig. 76 Argentina Country Dynamics
  • Fig. 77 Argentina Veterinary Pharmacovigilance Market, 2018 - 2030 (USD Million)
  • Fig. 78 MEA Veterinary Pharmacovigilance Market, 2018 - 2030 (USD Million)
  • Fig. 79 South Africa Country Dynamics
  • Fig. 80 South Africa Veterinary Pharmacovigilance Market, 2018 - 2030 (USD Million)
  • Fig. 81 Saudi Arabia Country Dynamics
  • Fig. 82 Saudi Arabia Veterinary Pharmacovigilance Market, 2018 - 2030 (USD Million)
  • Fig. 83 UAE Country Dynamics
  • Fig. 84 UAE Veterinary Pharmacovigilance Market, 2018 - 2030 (USD Million)
  • Fig. 85 Kuwait Country Dynamics
  • Fig. 86 Kuwait Veterinary Pharmacovigilance Market, 2018 - 2030 (USD Million)
  • Fig. 87 Company Categorization
  • Fig. 88 Company Market Position Analysis
  • Fig. 89 Strategic Framework
目次
Product Code: GVR-4-68040-052-1

Veterinary Pharmacovigilance Market Growth & Trends:

The global veterinary pharmacovigilance market size is expected to reach USD 1.91 billion by 2030, registering a CAGR of 13.6% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven by several factors, including the increasing incidence of adverse drug reactions in animals, the rising adoption of companion animals, and the growing demand for animal-derived food products. Additionally, the increasing regulatory scrutiny and the need for stringent safety standards have led to the development of new pharmacovigilance technologies and tools. Accenture for instance, offers a range of Veterinary Vigilance services that include ICSR Case Processing , VeDDRA Coding, Signal Detection, Literature Management, EvVetMPD support, and Regulatory Intelligence. Growing industry requirements for aggregate reporting, expedited reporting, and management of signals are expected to propel the market growth in the coming years.

The COVID-19 pandemic has had both negative and positive impacts on the animal health market While it has created challenges, it has also created opportunities for companies to adapt and innovate, and has highlighted the importance of monitoring the safety and efficacy of animal health products in the context of global health crises. This supported the awareness and adoption of veterinary pharmacovigilance solutions. The field is an emerging sector within the animal healthcare market. It involves monitoring the safety and effectiveness of veterinary medicines, vaccines, and other animal health products, and reporting any adverse reactions or incidents that may occur. This information is then used to improve the safety and quality of these products and to protect animal health.With the growing concern for animal welfare and the increasing demand for animal-based food products, the market has gained significant attention in recent years.

Initiatives by key market participants is another factor fueling the market growth. In June 2018, Medfiles opened a new office in Japan to cater to European and Japanese clients with a range of services. These include pharmacovigilance, clinical trials, and analytical services, among others. In February 2022, Ennov, a key market player opened a new office in the U.S. in response to successful growth in the North American market. This expanded the company's global footprint with a focus on building its pharmacovigilance capabilities. Ennov's pharmacovigilance offerings include case intake, triage, signal detection and management for customers from human and veterinary life sciences market.

Veterinary Pharmacovigilance Market Report Highlights:

  • One of the key trends in the veterinary pharmacovigilance market is the adoption of new technologies such as electronic reporting systems and data analytics tools. These technologies allow for more efficient and accurate monitoring of adverse events, and can help to identify potential safety issues before they become more serious.
  • The software segment dominated the global veterinary pharmacovigilance industry and accounted for the largest revenue share of 51.0% in 2024
  • By product, anti-infectives held the largest share of over 45.4% of the market in 2024. Biologics segment on the other hand, is estimated to grow at the highest rate of over 14% over the next few years.
  • The in-house segment led the market with the largest revenue share of 54.4% in 2024
  • Dogs in veterinary pharmacovigilance industry held the dominant position with the highest revenue share of 50.0% in 2024
  • North America dominated the market by region in 2024 with a share of about 40%. Asia Pacific region is estimated to grow at the fastest rate of over 15.4% from 2025 to 2030.
  • The veterinary pharmacovigilance market presents significant opportunities for companies that are able to innovate, differentiate themselves, and respond to the evolving needs of the animal health industry.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Solution
    • 1.2.2. Type
    • 1.2.3. Product
    • 1.2.4. Animal Type
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Veterinary Pharmacovigilance Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Veterinary Pharmacovigilance Market: Solution Business Analysis

  • 4.1. Solution Market Share, 2024 & 2030
  • 4.2. Solution Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Solution, 2018 to 2030 (USD Million)
  • 4.4. Software
    • 4.4.1. Software Market, 2018 - 2030 (USD Million)
  • 4.5. Services
    • 4.5.1. Services Market, 2018 - 2030 (USD Million)

Chapter 5. Veterinary Pharmacovigilance Market: Type Business Analysis

  • 5.1. Type Market Share, 2024 & 2030
  • 5.2. Type Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 5.4. In-house
    • 5.4.1. In-house Market, 2018 - 2030 (USD Million)
  • 5.5. Contract Outsourcing
    • 5.5.1. Contract Outsourcing Market, 2018 - 2030 (USD Million)

Chapter 6. Veterinary Pharmacovigilance Market: Product Business Analysis

  • 6.1. Product Market Share, 2024 & 2030
  • 6.2. Product Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 6.4. Biologics
    • 6.4.1. Biologics Market, 2018 - 2030 (USD Million)
  • 6.5. Anti-Infective
    • 6.5.1. Anti-Infective Market, 2018 - 2030 (USD Million)
  • 6.6. Other Product
    • 6.6.1. Other Product Market, 2018 - 2030 (USD Million)

Chapter 7. Veterinary Pharmacovigilance Market: Animal Type Business Analysis

  • 7.1. Animal Type Market Share, 2024 & 2030
  • 7.2. Animal Type Segment Dashboard
  • 7.3. Market Size & Forecasts and Trend Analysis, by Animal Type, 2018 to 2030 (USD Million)
  • 7.4. Dogs
    • 7.4.1. Dogs Market, 2018 - 2030 (USD Million)
  • 7.5. Cats
    • 7.5.1. Cats Market, 2018 - 2030 (USD Million)
  • 7.6. Other Animal Types
    • 7.6.1. Other Animal Types Market, 2018 - 2030 (USD Million)

Chapter 8. Veterinary Pharmacovigilance Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2024 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 8.4. North America
    • 8.4.1. North America Veterinary Pharmacovigilance Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Regulatory Framework
      • 8.4.2.3. Competitive Insights
      • 8.4.2.4. U.S. Veterinary Pharmacovigilance Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Regulatory Framework
      • 8.4.3.3. Competitive Insights
      • 8.4.3.4. Canada Veterinary Pharmacovigilance Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Regulatory Framework
      • 8.4.4.3. Competitive Insights
      • 8.4.4.4. Mexico Veterinary Pharmacovigilance Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Europe
    • 8.5.1. Europe Veterinary Pharmacovigilance Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
    • 8.5.2. Germany
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Regulatory Framework
      • 8.5.2.3. Competitive Insights
      • 8.5.2.4. Germany Veterinary Pharmacovigilance Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. UK
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Regulatory Framework
      • 8.5.3.3. Competitive Insights
      • 8.5.3.4. UK Veterinary Pharmacovigilance Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Regulatory Framework
      • 8.5.4.3. Competitive Insights
      • 8.5.4.4. France Veterinary Pharmacovigilance Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Regulatory Framework
      • 8.5.5.3. Competitive Insights
      • 8.5.5.4. Italy Veterinary Pharmacovigilance Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Regulatory Framework
      • 8.5.6.3. Competitive Insights
      • 8.5.6.4. Spain Veterinary Pharmacovigilance Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.7. Denmark
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Regulatory Framework
      • 8.5.7.3. Competitive Insights
      • 8.5.7.4. Denmark Veterinary Pharmacovigilance Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.8. Sweden
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Regulatory Framework
      • 8.5.8.3. Competitive Insights
      • 8.5.8.4. Sweden Veterinary Pharmacovigilance Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.9. Norway
      • 8.5.9.1. Key Country Dynamics
      • 8.5.9.2. Regulatory Framework
      • 8.5.9.3. Competitive Insights
      • 8.5.9.4. Norway Veterinary Pharmacovigilance Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific Veterinary Pharmacovigilance Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Regulatory Framework
      • 8.6.2.3. Competitive Insights
      • 8.6.2.4. Japan Veterinary Pharmacovigilance Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Regulatory Framework
      • 8.6.3.3. Competitive Insights
      • 8.6.3.4. China Veterinary Pharmacovigilance Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Regulatory Framework
      • 8.6.4.3. Competitive Insights
      • 8.6.4.4. India Veterinary Pharmacovigilance Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. Australia
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Regulatory Framework
      • 8.6.5.3. Competitive Insights
      • 8.6.5.4. Australia Veterinary Pharmacovigilance Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.6. South Korea
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Regulatory Framework
      • 8.6.6.3. Competitive Insights
      • 8.6.6.4. South Korea Veterinary Pharmacovigilance Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.7. Thailand
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Regulatory Framework
      • 8.6.7.3. Competitive Insights
      • 8.6.7.4. Thailand Veterinary Pharmacovigilance Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America Veterinary Pharmacovigilance Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Regulatory Framework
      • 8.7.2.3. Competitive Insights
      • 8.7.2.4. Brazil Veterinary Pharmacovigilance Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Regulatory Framework
      • 8.7.3.3. Competitive Insights
      • 8.7.3.4. Argentina Veterinary Pharmacovigilance Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8. MEA
    • 8.8.1. MEA Veterinary Pharmacovigilance Market Estimates and Forecasts, By Country, 2018 - 2030 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Regulatory Framework
      • 8.8.2.3. Competitive Insights
      • 8.8.2.4. South Africa Veterinary Pharmacovigilance Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Regulatory Framework
      • 8.8.3.3. Competitive Insights
      • 8.8.3.4. Saudi Arabia Veterinary Pharmacovigilance Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Regulatory Framework
      • 8.8.4.3. Competitive Insights
      • 8.8.4.4. UAE Veterinary Pharmacovigilance Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Regulatory Framework
      • 8.8.5.3. Competitive Insights
      • 8.8.5.4. Kuwait Veterinary Pharmacovigilance Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Participant Overview
  • 9.2. Company Market Position Analysis
  • 9.3. Company Categorization
  • 9.4. Strategy Mapping
  • 9.5. Company Profiles/Listing
    • 9.5.1. ArisGlobal
      • 9.5.1.1. Overview
      • 9.5.1.2. Financial Performance
      • 9.5.1.3. Product Benchmarking
      • 9.5.1.4. Strategic Initiatives
    • 9.5.2. Accenture
      • 9.5.2.1. Overview
      • 9.5.2.2. Financial Performance
      • 9.5.2.3. Product Benchmarking
      • 9.5.2.4. Strategic Initiatives
    • 9.5.3. Ennov
      • 9.5.3.1. Overview
      • 9.5.3.2. Financial Performance
      • 9.5.3.3. Product Benchmarking
      • 9.5.3.4. Strategic Initiatives
    • 9.5.4. Sarjen Systems Pvt. Ltd.
      • 9.5.4.1. Overview
      • 9.5.4.2. Financial Performance
      • 9.5.4.3. Product Benchmarking
      • 9.5.4.4. Strategic Initiatives
    • 9.5.5. Pharsafer Associates Limited
      • 9.5.5.1. Overview
      • 9.5.5.2. Financial Performance
      • 9.5.5.3. Product Benchmarking
      • 9.5.5.4. Strategic Initiatives
    • 9.5.6. Knoell
      • 9.5.6.1. Overview
      • 9.5.6.2. Financial Performance
      • 9.5.6.3. Product Benchmarking
      • 9.5.6.4. Strategic Initiatives
    • 9.5.7. Biologit
      • 9.5.7.1. Overview
      • 9.5.7.2. Financial Performance
      • 9.5.7.3. Product Benchmarking
      • 9.5.7.4. Strategic Initiatives
    • 9.5.8. Indivirtus
      • 9.5.8.1. Overview
      • 9.5.8.2. Financial Performance
      • 9.5.8.3. Product Benchmarking
      • 9.5.8.4. Strategic Initiatives
    • 9.5.9. Azierta Contract Science Support Consulting
      • 9.5.9.1. Overview
      • 9.5.9.2. Financial Performance
      • 9.5.9.3. Product Benchmarking
      • 9.5.9.4. Strategic Initiatives
    • 9.5.10. Oy Medfiles Ltd.
      • 9.5.10.1. Overview
      • 9.5.10.2. Financial Performance
      • 9.5.10.3. Product Benchmarking
      • 9.5.10.4. Strategic Initiatives